http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9739122-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9fdcfc016d06837fd8ffcda67af9542
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_19e927a2a0ffaa23ee591aab449994cf
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
filingDate 1997-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf2653c56d5b0a4709f681a34a0740b2
publicationDate 1997-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9739122-A3
titleOfInvention Isolated and cloned mast cell 78 kda phosphoprotein (mast cell degranulation inhibitory agent) and use thereof
abstract A 78 kDa mast cell protein (moesin) has been cloned from rats, and its cDNA and amino acid sequence determined. This protein is phosphorylated on specific serine and threonine residues by the action in mast cells of one or more protein kinase C isozymes, especially the κ isozyme, thereby producing a phosphoprotein that inhibits mast cell degranulation (Mast Cell Degranulation Inhibitor Agent). In vivo phosphorylation of this protein in mast cells can be stimulated by drugs such as cromolyn, nedocromil, flavonoids such as quercetin and kaempherol, and lodoxamide. Mast cell degranulation can be inhibited by administration of phosphomoesin phosphatase inhibitors. Tissues deficient in mast cell moesin can be identified with a labeled anti-moesin or anti-phosphomoesin antibody and treated by transfecting such mast cells with moesin cDNA in a viral vector such as an influenza virus vector.
priorityDate 1996-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0613945-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396575
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280863
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408749
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409391
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51380892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226491568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395967

Total number of triples: 30.